Influence of Formulation and Processing Factors on Stability of Levothyroxine Sodium Pentahydrate
Influence of Formulation and Processing Factors on Stability of Levothyroxine Sodium Pentahydrate
复制标题
DOI:
10.1208/s12249-010-9434-8
复制
发表时间:
2010-06-01
影响因子:
3.3
通讯作者:
Khan, Mansoor A.
中科院分区:
文献类型:
--
作者:
Collier, Jarrod W.;Shah, Rakhi B.;Khan, Mansoor A.
Stability of formulations over shelf-life is critical for having a quality product. Choice of excipients, manufacturing process, storage conditions, and packaging can either mitigate or enhance the degradation of the active pharmaceutical ingredient (API), affecting potency and/or stability. The purpose was to investigate the influence of processing and formulation factors on stability of levothyroxine (API). The API was stored at long-term (25A degrees C/60%RH), accelerated (40A degrees C/75%RH), and low-humidity (25A degrees C/0%RH and 40A degrees C/0%RH) conditions for 28 days. Effect of moisture loss was evaluated by drying it (room temperature, N-2) and placed at 25A degrees C/0%RH and 40A degrees C/0%RH. The API was incubated with various excipients (based on package insert of marketed tablets) in either 1:1, 1:10, or 1:100 ratios with 5% moisture at 60A degrees C. Commonly used ratios for excipients were used. The equilibrium sorption data was collected on the API and excipients. The API was stable in solid state for the study duration under all conditions for both forms (potency between 90% and 110%). Excipients effect on stability varied and crospovidone, povidone, and sodium laurel sulfate (SLS) caused significant API degradation where deiodination and deamination occurred. Moisture sorption values were different across excipients. Crospovidone and povidone were hygroscopic whereas SLS showed deliquescence at high RH. The transient formulation procedures where temperature might go up or humidity might go down would not have major impact on the API stability. Excipients influence stability and if possible, those three should either be avoided or used in minimum quantity which could provide more stable tablet formulations with minimum potency loss throughout its shelf-life.